| Jamie Marie Bigelow, MD | |
|
815 Hyde St, San Francisco, CA 94109-5996 | |
| (415) 673-7515 | |
| (415) 563-6259 |
| Full Name | Jamie Marie Bigelow |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 34 Years |
| Location | 815 Hyde St, San Francisco, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043393663 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Medical Center | San francisco, CA | Hospital |
| Saint Francis Memorial Hospital | San francisco, CA | Hospital |
| Entity Name | Hyperbaric Consultants Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093142085 PECOS PAC ID: 0547490864 Enrollment ID: O20140307000216 |
News Archive
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
Experts from the Johns Hopkins Center for Sleep hope to help patients get a better night's sleep by providing health care staff members with a basic educational tool on their smartphones.
An interactive preclinical PET-MR workshop with demonstrations of a new 7T integrated PET-MR multi-modality imaging system from MR Solutions and presentations from participants was held in Dijon last week.
SIMPLE Antibody(TM) Platform Delivers Unprecedented Choice of Ultra-Potent Functional Antibody Leads Against Challenging Soluble and Cell Surface Targets. - ARGX-109, a Fully Human mAb Targeting Autoimmune, Inflammation and Oncology Indications, Enters Preclinical Development in Less Than 12 Months From Start of Discovery.
A saliva test could fast track heart attack diagnosis, according to preliminary research presented today at ESC Congress 2020.
› Verified 2 days ago
| Entity Name | Hyperbaric Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548630007 PECOS PAC ID: 2668773276 Enrollment ID: O20151223000673 |
News Archive
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
Experts from the Johns Hopkins Center for Sleep hope to help patients get a better night's sleep by providing health care staff members with a basic educational tool on their smartphones.
An interactive preclinical PET-MR workshop with demonstrations of a new 7T integrated PET-MR multi-modality imaging system from MR Solutions and presentations from participants was held in Dijon last week.
SIMPLE Antibody(TM) Platform Delivers Unprecedented Choice of Ultra-Potent Functional Antibody Leads Against Challenging Soluble and Cell Surface Targets. - ARGX-109, a Fully Human mAb Targeting Autoimmune, Inflammation and Oncology Indications, Enters Preclinical Development in Less Than 12 Months From Start of Discovery.
A saliva test could fast track heart attack diagnosis, according to preliminary research presented today at ESC Congress 2020.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jamie Marie Bigelow, MD Po Box 1023, Novato, CA 94948-1023 Ph: (415) 234-6100 | Jamie Marie Bigelow, MD 815 Hyde St, San Francisco, CA 94109-5996 Ph: (415) 673-7515 |
News Archive
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
Experts from the Johns Hopkins Center for Sleep hope to help patients get a better night's sleep by providing health care staff members with a basic educational tool on their smartphones.
An interactive preclinical PET-MR workshop with demonstrations of a new 7T integrated PET-MR multi-modality imaging system from MR Solutions and presentations from participants was held in Dijon last week.
SIMPLE Antibody(TM) Platform Delivers Unprecedented Choice of Ultra-Potent Functional Antibody Leads Against Challenging Soluble and Cell Surface Targets. - ARGX-109, a Fully Human mAb Targeting Autoimmune, Inflammation and Oncology Indications, Enters Preclinical Development in Less Than 12 Months From Start of Discovery.
A saliva test could fast track heart attack diagnosis, according to preliminary research presented today at ESC Congress 2020.
› Verified 2 days ago
Dr. Pratyusha Kishore Narra, MBBS Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3490 California St, San Francisco, CA 94118 Phone: 415-514-6200 Fax: 415-514-6410 | |
Dr. Chelsea Joy Thomsen, M.D., M.S.P.H Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2 W Portal Ave, San Francisco, CA 94127 Phone: 415-291-0480 | |
Christine Soran, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1001 Potrero Ave, Bldg 10, 3rd Floor, Ward 13, Ucsf Division Of General Internal Medicine Sfgh, San Francisco, CA 94110 Phone: 415-206-5164 Fax: 415-206-5586 | |
Stephen Norris Cohen, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 40 Ventura Ave, San Francisco, CA 94116 Phone: 415-681-2171 Fax: 415-681-2171 | |
Mauricio Jalife Bucay, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-750-4994 Fax: 415-750-8156 | |
Dr. Adriana A.t. Martin, M.D., PH.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-514-7288 | |
Dr. Alexandra Cristina Villasante Fricke, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 655 Montgomery St Ste 810, San Francisco, CA 94111 Phone: 844-847-8216 Fax: 415-520-9150 |